SciELO - Scientific Electronic Library Online

 
vol.23 special issueUse of Glucocorticoids in Duchenne Muscular Dystrophy Patients author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Ciencias de la Salud

Print version ISSN 1692-7273On-line version ISSN 2145-4507

Abstract

HUERTAS-QUINONES, Manuel et al. Diagnosis and Management of Cardiac Complications in the Patient with Duchenne Muscular Dystrophy. Rev. Cienc. Salud [online]. 2025, vol.23, n.spe, e23e12.  Epub Apr 08, 2025. ISSN 1692-7273.  https://doi.org/10.12804/revistas.urosario.edu.co/revsalud/a.13637.

Duchenne muscular dystrophy is the most common and severe muscular dystrophy in childhood. As the disease progresses, there is evidence of cardiac muscle involvement with the presence of dilated cardiomyopathy and hypertrophic or restrictive cardiomyopathy, leading to heart failure. Currently, there is no curative treatment for Duchenne muscular dystrophy or its cardiovascular complications. However, the use of glucocorticoids, physical rehabilitation, non-invasive mechanical ventilation, and multidisciplinary management with a cardiorespiratory and orthopedic focus have been shown to modify the natural history of the disease. This article provides a synthesis of the diagnosis and treatment of patients diagnosed with Duchenne muscular dystrophy who present cardiovascular complications.

Keywords : Duchenne; cardiac; hypertrophic cardiomyopathy; dilated cardiomyopathy.

        · abstract in Spanish | Portuguese     · text in Spanish     · Spanish ( pdf )